Item 9 Labs Corp. strengthens its board of directors with the appointment of the founder of Massage Heights

PHOENIX , March 2, 2022 /PRNewswire/ — Item 9 Labs Corp. (OTCQX: INLB) (the “Company”) – the first true franchisor and vertically integrated cannabis dispensary operator that manufactures premium, award-winning products – announced today that Shane Evansfounder of Massage Heights, was appointed to its board of directors.

“The addition of Shane to our Board of Directors brings an invaluable level of experience in the wellness and franchise industries to our Item 9 Labs and Unity Rd brands,” said Andrew BowdenCEO of Item 9 Labs Corp. “His guidance will strengthen our position as the premier vertically integrated national cannabis franchisor in the United States and will be essential in growing the Unity Rd. franchise network.”

Currently, the Company’s cannabis dispensary franchise brand, Unity Rd., has a store owned by a franchise partner operating in Boulder, Coloradoas well as a store with a Local Alliance Partner at Oklahoma City. Path of unity. has signed agreements with nearly 20 groups of entrepreneurs who are at various stages of development across Maine, Michigan, New Jersey, Virginia and more. With more than 20 podiums in Arizona marijuana contest, Item 9 Labs is a trusted source for premium cannabis products. Beginning with intentionally grown flowers, the Item 9 Labs product catalog covers over 100 products in five main categories, including multiple active cannabis strains, cannabis vaping products, premium concentrates, and Orion vaping technology. .

The company plans to expand Item 9 Labs products alongside the Unity Rd. franchise network to provide franchise partners preferred access to a reliable, high-quality supply chain and consumers nationwide consistency in the products they expect franchises. To accelerate national growth, Item 9 Labs Corp. actively seeks dispensary acquisitions in key markets nationwide. The company plans to convert the cannabis retail stores to Unity Rd. stores, train the local team, and sell the business to new and existing Unity Rd. franchise partners.

On Shane Evans

Evans has been heavily involved in the health and wellness industry for over two decades. She co-founded Massage Heights in 2004 and began franchising the concept in 2005. Under her leadership, the spa franchise has grown to over 120 retreats across North America. Today, she continues to support Massage Heights as Vice Chair of the Board.

“Shane’s franchise success has been inspiring to watch,” said Item 9 Labs Corp.’s Director of Franchise, Michael Weinberger, who has been in the franchise for 20 years. “His experience leading and developing a fast-growing franchise concept brings tremendous value to the development of our Unity Rd. franchise.”

Evans also co-owns several Massage Heights outlets; Supply Chain Co-Owner, Summit Franchise Supply, LLC; Co-owner of The Gents Place, an ultra-premium men’s grooming franchise; and serves on the board of the Massage Heights Family Fund, a 501c3 crisis fund for team members in need. She has also been a dedicated member of the Young Presidents Organization (YPO) alongside Bowden since 2015, sits on the Franchise Relations Committee of the International Franchise Association (IFA) and is an active member of the Franchisor Forum. Evans has been recognized as one of the franchise industry’s top founders and has been featured in several national business media as well as franchise trade publications.

“I’ve always been extremely passionate about getting involved with organizations that make a difference in their industry and their communities,” Evans said. “Item 9 Labs Corp. brings high-quality alternative medicine to those in need, while opening the door to cannabis entrepreneurship through the franchise model. I look forward to applying my experience to help further strengthen the company’s position as a leader in the space and continue to pave its way to exponential growth.”

In January 2022the Company has added two additional independent directors, Eric C. Kutscher, Pharma. D., MBA, FASHP, and Lawrence X. Taylor, who have a combined 55 years of experience in patient-centered healthcare, leadership, mergers and acquisitions, and strategic planning. Their appointments alongside Evans reinforce the leadership and positive momentum of Item 9 Labs Corp. in the field of cannabis and franchising.

For more information on Item 9 Labs Corp. and its marks, visit https://investors.item9labscorp.com/.

About Item 9 Labs Corp.
Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis operator and dispensary franchisor that offers premium products from its large-scale cultivation and production facilities in the United States. Award-winning brand Item 9 Labs specializes in the best products and user experience across multiple cannabis categories. The company also offers a unique dispensary franchise model through the nationwide Unity Rd. retail brand. By lowering barriers to entry, franchising provides an opportunity for new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. Item 9 Labs brings industry best practices to markets nationwide through a distinctive retail experience, culture capabilities and product innovation. The seasoned management team combines a diverse skill set with deep experience in the cannabis industry, franchising and capital markets to lead a new generation of public cannabis companies that deliver transparency, consistency and well-being. Based in Arizona, the company is currently expanding its operating space by more than 640,000 square feet on its 50-acre site, one of the largest properties in Arizona zoned for growing and growing flowers. For more information, visit item9labscorp.com.

Forward-looking statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties, including, but not limited to, the risks and effects of judicial and administrative proceedings and governmental proceedings. regulation, particularly in a foreign country, future financial and operating results, competition, general economic conditions, proposed transactions that are not legally binding on the company and the ability to manage and pursue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this press release include the introduction of new technologies, market conditions and those set forth in any reports or documents we file from time to time. another with the SEC. We undertake no obligation to revise or update these statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unforeseen events.

Media Contact:
Section 9 Labs Corp.
Jayne Levyvice president of communications
E-mail: [email protected]

Investor contacts:
Section 9 Labs Corp.
800-403-1140
E-mail: [email protected]

SOURCE Element 9 Labs Corp.

Comments are closed.